Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125542363 | 12554236 | 3 | F | 20160715 | 20160713 | 20160802 | PER | US-PFIZER INC-2016318688 | PFIZER | 61.00 | YR | F | Y | 79.37000 | KG | 20160802 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125542363 | 12554236 | 1 | PS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Oral | 30 MG, 4X/DAY (ONE TABLET,EVERY 6 HOURS) | 19999 | 30 | MG | QID | |||||||
125542363 | 12554236 | 2 | SS | MORPHINE | MORPHINE | 1 | Oral | 60 MG, 2X/DAY(ONCE IN AM AND ONCE IN PM ) | IMP2311 | 0 | 60 | MG | MODIFIED-RELEASE TABLET | BID | |||||
125542363 | 12554236 | 3 | SS | IRON | IRON | 1 | UNK (TAKE 1 EVERY 3 DAYS.) | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125542363 | 12554236 | 1 | Breakthrough pain |
125542363 | 12554236 | 2 | Pain |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125542363 | 12554236 | Condition aggravated | |
125542363 | 12554236 | Constipation | |
125542363 | 12554236 | Drug effect incomplete |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125542363 | 12554236 | 1 | 2015 | 0 | ||
125542363 | 12554236 | 2 | 2015 | 0 |